Portuguese 
English 
Spanish 
3 min of reading 
1 comment 
The Proposal Aims to Expand the Use of Brain Implant in 2026, with Mass Manufacturing and a More Automated Implantation Method
Elon Musk wants to take the brain chips from Neuralink to a new level starting in 2026, with large-scale production and an automated surgical procedure to implant the device.
The change could accelerate the availability of the implant for patients with severe mobility limitations, as it involves both mass manufacturing and automation of the implantation process.
What Happened and Why It Got Attention
Neuralink is one of the companies linked to Elon Musk, alongside Tesla, SpaceX, X Corp, and xAI, among others, totaling more than 5 companies in its portfolio.
-
While the world looks at oil, the war with Iran is already disrupting helium supply from Qatar, affecting car and iPhone chips, threatening AI expansion, and putting pressure on aluminum packaging at the highest value in four years.
-
Global warming will expose a treasure hidden under the ice of Antarctica and may spark an international dispute over gold and valuable minerals.
-
A street vendor from Praia Grande built a robot made of scrap from scooters and washing machines that pulls his popcorn cart on the beach, emits sounds, and interacts with customers, becoming an attraction on the coast of São Paulo.
-
The specifications of the Xiaomi 18 Pro Max have been leaked, and the highlight is a dual 200 MP camera with a new 22-nanometer technology that promises to consume less energy and capture details in shadows and bright areas using LOFIC HDR.
Now, the proposal is to initiate a phase of mass production of brain chips in 2026 and advance to a model of automated surgery.
The topic draws attention because it deals with brain implants with direct interface between mind and computer, something that for a long time seemed distant from real use.
How Neuralink Got Here
The attempt to implant the chip in humans faced regulatory barriers for years, with the FDA preventing the advancement to human trials at different times.
During this period, animal tests were conducted, including demonstrations in which monkeys managed to play Pong using their minds.
The approval for human use happened, and in 2024, the first human with a Neuralink chip was seen, although issues arose after this milestone.
How the Brain-Machine Interface Works in Practice
The central idea is to connect the brain to an interface that allows communication and control of devices using neural signals.
In practice, this paves the way for tasks such as operating a computer and, with training, even playing video games, maintaining activities that many believed would be lost after paralysis.
The focus is a very specific use aimed at those with limited mobility, rather than a widely consumed product.
What Changes in Practice for Patients with Severe Paralysis
Neuralink operates in a niche, but demand has reportedly grown to the point of motivating the transition to large-scale production.
In addition to manufacturing, the plan includes an automated procedure for implanting the chip, indicating an attempt to standardize and accelerate the surgical phase.
The practical promise of this model is to reduce installation bottlenecks, as the process no longer depends solely on a traditional surgical flow.
What Are the Rules, Deadlines, and Conditions Cited
The main milestone mentioned is 2026, the year expected for the start of large-scale manufacturing and the adoption of the automated implantation method.
There is also a current adoption figure: there are 12 patients in the world using brain chips from Neuralink, all with severe paralysis.
In cases of chip failures in one of the patients, it was reported that there was correction through software updates, which keeps the topic of reliability in focus.
What Could Happen from Now On
The proposed scale is likely to put more pressure on safety, stability, and long-term monitoring, as future results are still unknown.
The plan gains more context after the company raised 650 million dollars in a funding round in June 2025, reinforcing its capacity to fund expansion.
If mass production and automated implantation advance as planned, Neuralink could expand the reach of the implant within the audience it already serves today.
The central point is that Elon Musk aims for 2026 to scale up Neuralink, uniting mass manufacturing and automated surgery in the implantation of the chip.
With 12 patients already implanted and 650 million dollars raised in June 2025, the company enters a phase where the impact could grow, but still faces natural doubts about long-term results.
A volta de Jesus está cada vez mais perto